All articles by

Mawi gets CE mark for non-invasive sample collection devices

Mawi DNA Technologies, a provider of biosample collection technologies, has secured CE mark approval for its iSWAB non-invasive collection devices.…

FDA approves Biobot Surgical’s new robotic-assisted transperineal needle-guidance system

Biobot Surgical has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its new robotic-assisted transperineal needle-guidance system…

LumiThera acquires visual electrophysiology devices company Diopsy

Commercial stage medical device firm LumiThera has wrapped up the acquisition of modern visual electrophysiology medical devices provider Diopsys for…

Gleamer’s BoneView AI software gets FDA clearance

French medtech company Gleamer has secured approval from the US Food and Drug Administration (FDA) for its BoneView artificial intelligence…

Swift Medical Launches World’s First All-in-One Hyperspectral Imaging Device to Make Healthcare More Accessible

Swift Medical, the global leader in digital wound care technology, unveiled the Swift Ray 1, a groundbreaking hardware device that…

FineHeart announces new patent for ICOMS FLOWMAKER

FineHeart S.A, a preclinical medical device company that has developed the ICOMS FLOWMAKER®, a fully Implantable Cardiac Output Management System…

ExThera Medical recruits first patient in Seraph 100 blood filter trial

ExThera Medical has announced the recruitment of the first patient in the blood purification for the treatment of pathogen associated…

Intrivo introduces On/Go One rapid Covid-19 test

Health-technology company Intrivo has launched its rapid Covid-19 test called On/Go One for the detection of all major known variants,…

The Argos Cardiac Output Monitor Interface is Declared Compatible with Philips IntelliBridge

Retia Medical today announced that it received a Declaration of Compatibility from Philips for its Argos Cardiac Output Monitor to…

FDA Approves Kaléo’s 10 mg Naloxone Auto-Injector for Treatment of Known or Potential Exposure to Ultra-Potent Weaponized Opioids

Kaléo, a privately held U.S. pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved its…